Chinese Plant Compound , Triptolide Wipes out Cancer in 40 Days, Say new Research. Triptolide is a diterpenoid epoxide found in the Thunder God Vine, Tripterygium wilfordii. It has in vitro and in vivo activities againstmouse models of polycystic kidney disease[1] and http://en.wikipedia.org/wiki/Pancreatic_cancer” rel=”nofollow”>pancreatic cancer, but its physical properties limit its therapeutic potential.[2] Consequently, a synthetic prodrug, minnelide, is being studiedclinically instead.[2] A little-known plant with a truly bizarre name is now making headlines… Continue reading Chinese Plant Compound , Triptolide Wipes out Cancer in 40 Days, Say new Research.
Category: cancer
Breast Cancer Drugs in Late-Stage Development/Recently Approved
The article is 2012-2013 based and reader discretion is sought to ascertian the stage of approval Breast Cancer Drugs in Late-Stage Development/Recently Approved Afinitor® (everolimus) http://newdrugapprovals.wordpress.com/2013/04/27/drug-spotlight-afinitor-everolimus-novartis/ Sponsor: Novartis Method of Action: Mammalian target of rapamycin (mTOR) inhibitor Indications/Phase of Trial: Hepatocellular carcinoma; human epidermal growth factor receptor 2-positive (HER2+) breast cancer first-line and second-line; lymphoma; nonfunctional carcinoid… Continue reading Breast Cancer Drugs in Late-Stage Development/Recently Approved
From Cholesterol to Breast Cancer
The conversion of cholesterol into 27-hydroxycholesterol promotes the growth of hormone-dependent breast cancer Read more From Cholesterol to Breast Cancer
The first generic version of the oral chemotherapy drug Xeloda (capecitabine) has been approved by the U.S. Food and Drug Administration to treat cancers of the colon/rectum or breast
capecitabine 154361-50-9 R-340, Ro-09-1978, Xeloda pentyl [1-(3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoro-2-oxo-1H-pyrimidin-4-yl]carbamate MONDAY Sept. 16, 2013 — The first generic version of the oral chemotherapy drug Xeloda (capecitabine) has been approved by the U.S. Food and Drug Administration to treat cancers of the colon/rectum or breast, the agency said Monday in a news release. This year, an estimated 142,820 people… Continue reading The first generic version of the oral chemotherapy drug Xeloda (capecitabine) has been approved by the U.S. Food and Drug Administration to treat cancers of the colon/rectum or breast
Breast-Feeding May Protect Some Women Against Breast Cancer
The Guardian Breast-Feeding May Protect Some Women Against BreastCancer Health.com - “There are various explanations why breast-feeding seems to preventbreast cancer,” Gonzalez-Jimenez said. “The most probable of these are … read all at http://news.health.com/2013/08/15/breast-feeding-may-protect-some-women-against-breast-cancer/ By Kathleen Doheny HealthDay Reporter